Search

Author/Creator Davis, Gershan

11. Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial. Issue 10369 (17th December 2022)

Authors:
Kalra, Paul R; Cleland, John G F; Petrie, Mark C; Thomson, Elizabeth A; Kalra, Philip A; Squire, Iain B; Ahmed, Fozia Z; Al-Mohammad, Abdallah; Cowburn, Peter J; Foley, Paul W X; Graham, Fraser J; Japp, Alan G; Lane, Rebecca E; Lang, Ninian N; Ludman, Andrew J; Macdougall, Iain C; Pellicori, Pier...
Journal:
Lancet
Issue:
Volume 400:Issue 10369(2022)
Page Start:
2199
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

13. Potential use of PCSK9 inhibitors as a secondary preventative measure for cardiovascular disease following acute coronary syndrome: a UK real-world study. Issue 1120 (1st February 2019)

Authors:
Elamin, Ahmed Farouk Mohamed; Grafton-Clarke, Ciaran; Wen Chen, Kai; Obafemi, Toba; Luvai, Ahai; Katira, Ravish; Davis, Gershan
Journal:
Postgraduate medical journal
Issue:
Volume 95:Issue 1120(2019)
Page Start:
61
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗